Cystic fibrosis patients lose up to five times more sodium and chlorine with sweat than a healthy population, incurring a serious risk of dehydration.
A correct saline supplementation is recommended in cystic fibrosis patients to maintain optimal levels of salts in the body in order to prevent dehydration. These patients not only experience a high risk of dehydrationin summertime due to high temperatures, but also in winter.
In winter season the risk of dehydration is severe, either due to the highly recommended physical activity that these patients perform, or due to fever conditions caused by the frequent and severe bacterial infections to which these patients are highly sensitive.
Wadi is a food for special medical purposes in tablet form; it is easy to take and represents a practical, innovative and simple solution to saline supplementation in CF patients, for all patients at any time of the year.
The product must be used under prescription and medical supervision.
